Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute
API

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

Ancilia Biosciences, INC. — Funding, Investors & Profile — Capbase

← All companies

Compare History

Ancilia Biosciences, INC.

Private

Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: LYP2JAHDAA77

Founded: —Source: [GOV]
Headquarters: NEW YORK, New YorkSource: [GOV]
Country: United StatesSource: [GOV]
Headcount: 7Source: [GOV]
Stage

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

Ancilia Biosciences, INC. has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $530,118 between 2021 and 2024. These are non-dilutive federal research grants, not equity financing. The company is based in NEW YORK, New York.

Funding rounds

2 rounds

2 rounds · latest STTR Phase I award (HHS), Sep 2024

Investors

No investors recorded yet for Ancilia Biosciences, INC..

Add an investor

People

Leadership

MATTHEW H FOLEYPrincipal investigatorSince 2024Source: [GOV]

Alexandra SakatosPrincipal investigatorSince 2021Source: [GOV]

Acquisitions

Ancilia Biosciences, INC. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for Ancilia Biosciences, INC..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Seed

Sector

Healthcare